Online ISSN: 1945-4589
www.aging-us.com
About Aging
Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.

LEARN MORE ABOUT AGING

Prognostic Significance of Senescence-related TME Genes in Head and Neck Squamous Cell Carcinoma

Aging

January 31, 2024
PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 16, Issue 2, entitled, “Prognostic significance of senescence-related tumor microenvironment genes in head and neck squamous cell carcinoma.” continue reading »

XRCC1: A Potential Prognostic and Immunological Biomarker in Low-Grade Gliomas

Aging

January 30, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 1, entitled, “XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.” continue reading »

Targeting FSP1 Regulates Iron Homeostasis in Drug-tolerant Persister Head and Neck Cancer Cells

Aging

January 24, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 1, entitled, “Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.” continue reading »

Systematic Analysis of the Prognostic Value and Immunological Function of LTBR in Cancer

Aging

January 23, 2024
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 1, entitled, “Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.” continue reading »

Efficacy and Safety of EGFR-TKIs for Elderly Patients With NSCLC

Aging

January 18, 2024
In a new study, researchers investigated the effectiveness and safety of EGFR-tyrosine kinase inhibitors in elderly patients with EGFR-mutated advanced non-small-cell lung cancer (NSCLC). continue reading »